{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiezupmng6oqxhgxdmvrvuu6caxjfrhpqnzzy43ziegihjjksb5gne",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mn24ro6nt7t2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie5lihev6ayyj2jermmrqlbjpzt5ewjdwgjtivvs66kojakfcjp4a"
    },
    "mimeType": "image/jpeg",
    "size": 123250
  },
  "path": "/2026/05/29/asco-news-day-1-multiple-myeloma-bristol-lung-cancer-pfizer/?utm_campaign=rss",
  "publishedAt": "2026-05-29T21:32:26.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Health",
    "Pharma",
    "ASCO",
    "biotechnology",
    "Cancer",
    "drug development",
    "FDA",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here. We’re ASCOmaxxing. Rest…",
  "title": "STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer",
  "updatedAt": "2026-05-29T23:01:38.000Z"
}